Literature DB >> 8606595

Leukaemia risk in Crohn's disease.

K Hatake, M Tanaka, K Muroi, Y Miura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8606595     DOI： 10.1016/s0140-6736(96)90191-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Crohn's disease in leukemia: report of a case, with a review of the literature.

Authors:  Jawad A Makarem; Zaher K Otrock; Ala I Sharara; Ali T Taher
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

2.  Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn's disease accompanied by chronic myeloid leukemia.

Authors:  Tsutomu Mizoshita; Satoshi Tanida; Shigeru Kusumoto; Keiji Ozeki; Hironobu Tsukamoto; Masahide Ebi; Yoshinori Mori; Hiromi Kataoka; Takeshi Kamiya; Takashi Joh
Journal:  Clin J Gastroenterol       Date:  2012-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.